Is Barclays PLC A Promising Capital-Growth Investment?

BarclaysWith last week’s interim results from Royal Bank of Scotland revealing a sharp rise in profits, all eyes turn to Barclays (LSE: BARC), due to release its own interims on 30 July.

There’s a good chance that we’ll see profits on the rise at Barclays, too. So does that make the firm a good candidate for a capital-growth vehicle? I don’t think so.

Is the valuation flagging a warning?

City analysts following Barclays seem to think that profits will increase, predicting a 39% lift this year followed by a 23% rise in 2015. At today’s share price of 218p, the forward P/E ratings come in at around 9.4 and 7.6 respectively. When you consider that with the forward dividend yield, running at just under 5% for 2015, Barclays looks good value on traditional valuation indicators.

The trouble is that traditional valuation indicators don’t work very well for cyclical shares such as Barclays. In fact, they tend to work in reverse, so a high yield and a low P/E rating could be warning investors to keep away.

Barclays’ share-price chart for the last four years reveals a downward trend, just as profits are rising. That situation works against a successful capital-growth investment and can even nullify shareholder gains from dividend income. But why is it happening? The answer to that question seems to be in the way that the stock market looks constantly forward. Cyclicals tend to see their profits rise and fall along with macro-economic cycles. So the stock market knows that rising profits will lead to a profit peak, which precedes another profit decline. So, to keep one step ahead, the market tends to de-rate P/E valuations as profits rise. There’s no doubt about it: timing an investment in cyclical companies is tricky mid-cycle.

Where’s the cash?

The last cyclical bottom hit the banks particularly hard and Barclays struggles to purge legacy issues from its system. The firm is fighting to de-leverage from a position of dizzyingly high financial gearing, and to de-risk its business for reputation and conduct, after a string of conduct-related scandals.

Reform like that takes buckets of cash and Barclays didn’t have enough, which caused it to host a £5.8 billion dilutive Rights Issue last year. You can see why the firm needed extra funds when you look at the cash record:

Year to December 2009 2010 2011 2012 2013
Cash at bank (£m) 81,483 97,630 106,894 86,191 45,687
Net cash from operations (£m) 41,844 18,686 29,079 (13,823) (25,174)
Net cash from investing (£m) 11,888 (5,627) (1,912) (7,097) (22,645)
Net increase/decrease in cash (£m) 49,831 17,060 18,273 (27,873) (41,711)

I don’t think you need look much further than that table to see what keeps Barclays on a low rating. A firm’s ability to generate and hang onto cash is its most fundamental measure of worth, and in recent years, Barclays looks like a basket case.

Before Barclays stands any chance of halting or reversing its share price decline, I think we must see a robust turnaround in its cash fortunes. Therefore, I’ll be looking for clues with this month’s interim statement, but reserving judgement on the firm’s financial progress until the full-year results are in at the beginning of next year.

What now?

One thing that I definitely won’t be doing is investing in Barclay’s right now. I’m looking for firms with bright growth prospects and as little cyclicality in their operations as possible.

That's why I'm keen on a share idea for capital gains from one of the Motley Fool's top small-cap investors. His diligent research has uncovered what looks like one of the best growth shares for 2014.

A strong recovery in profits at this company followed restructuring, and the directors predict double-digit margins driving a profits surge in the years to come. We could see the shares delivering total investor returns measured by hundreds of percent over the next few years.

For a limited period, this investor wealth report is downloadable free. To get your copy, click here.

Kevin Godbold has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned.